ARTA
OSIR

A.R.T. Advisors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

A.R.T. Advisors’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-23,049
Closed -$117K – 1566
2016
Q2 		$117K Buy
+23,049
New +$124K 0.01% 1187
2016
Q1 		– Sell
-27,049
Closed -$280K – 1925
2015
Q4 		$280K Buy
+27,049
New +$367K 0.01% 1082
2015
Q3 		– Sell
-31,699
Closed -$616K – 1868
2015
Q2 		$616K Sell
31,699
-6,123
-16% -$108K 0.02% 915
2015
Q1 		$664K Buy
+37,822
New +$635K 0.02% 809

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

A.R.T. Advisors's OSIR Position: Q3 2016 in Review

A.R.T. Advisors sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q3 2016, closing a stake of 23,049 shares — an estimated $117K sold.

A.R.T. Advisors first reported a position in OSIR in Q1 2015 and held it in 4 quarters. The position peaked at $664K in Q1 2015. 63 funds tracked by Wall St. Rank hold OSIR as of Q3 2016.

  • A.R.T. Advisors reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • A.R.T. Advisors sold 23,049 Osiris Therapeutics, Inc. Common Stock shares in Q3 2016, an estimated $117K.
  • A.R.T. Advisors first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2015 and held it in 4 quarters.
  • A.R.T. Advisors's Osiris Therapeutics, Inc. Common Stock position peaked at $664K in Q1 2015.
  • 63 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q3 2016.

Based on A.R.T. Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.